patient
symptom
travel
histori
suggest
might
middl
east
respiratori
syndrom
frighten
often
fatal
viral
infect
man
age
year
caucasian
present
hospit
histori
fever
dri
cough
also
sore
throat
headach
mild
epigastr
discomfort
addit
notic
skin
rash
day
admiss
return
busi
trip
unit
arab
emir
day
earlier
recal
contact
anim
sick
peopl
ill
enjoy
good
health
admiss
patient
fever
f
c
physic
examin
reveal
gener
blanchabl
macular
rash
trunk
spare
limb
head
neck
figur
chest
auscult
disclos
inspiratori
crackl
right
lower
zone
result
complet
blood
count
show
total
leukocyt
count
cellsmm
hemoglobin
gdl
platelet
count
plateletsml
patient
neutrophil
count
normal
cellsmm
mild
lymphopenia
cellsmm
note
liver
function
mildli
derang
demonstr
elev
serum
alanin
aminotransferas
ul
aspart
aminotransferas
ul
serum
bilirubin
normal
mgdl
mmoll
alkalin
phosphatas
ul
patient
erythrocyt
sediment
rate
mmh
serum
creactiv
protein
level
mgdl
mildli
elev
chest
radiograph
show
right
middl
zone
hazi
figur
contrastenhanc
comput
tomographi
thorax
display
groundglass
chang
lower
lobe
right
lung
figur
diagnosi
communityacquir
pneumonia
made
patient
travel
arabian
peninsula
day
symptom
onset
admit
airborn
infect
isol
precaut
suspect
middl
east
respiratori
syndrom
howev
nasopharyng
aspir
test
neg
reversetranscript
polymeras
chain
reaction
indirect
immunofluoresc
middl
east
respiratori
syndrom
coronaviru
coronavirus
influenza
virus
parainfluenza
virus
respiratori
syncyti
viru
human
metapneumoviru
adenoviru
elimin
differenti
diagnosi
polymeras
chain
reaction
test
nasopharyng
aspir
pathogen
atyp
pneumonia
includ
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
pneumophila
also
provid
neg
result
sputum
blood
cultur
neg
urin
sampl
test
l
pneumophila
serogroup
antigen
serum
monospot
test
infecti
mononucleosi
human
immunodefici
viru
antibodi
test
explor
contact
histori
patient
report
episod
roseola
infantum
commonli
refer
roseola
daughter
week
earlier
anoth
nasopharyng
aspir
sampl
retriev
test
posit
human
herpesviru
dna
polymeras
chain
reaction
primer
target
gene
sequenc
confirm
viru
human
herpesviru
serum
obtain
day
symptom
onset
neg
human
herpesviru
dna
patient
diagnosi
atyp
pneumonia
caus
human
herpesviru
base
sever
line
evid
includ
recent
contact
child
suspect
roseola
also
known
exanthema
subitum
sixth
diseas
common
often
selflimit
pediatr
ailment
caus
human
herpesviru
consider
develop
characterist
roseolalik
macular
skin
rash
day
fever
lack
evid
bacteri
viral
caus
pneumonia
detect
human
herpesviru
dna
nasopharyng
aspir
symptomat
phase
ill
demonstr
human
herpesviru
caus
pneumonia
mimick
form
viral
pneumonia
immunocompet
individu
descript
human
herpesviru
pneumonia
rare
among
immunocompet
patient
one
report
immunocompet
adult
sever
legionellosi
detail
concurr
isol
human
herpesviru
antigen
blood
inflammatori
cell
lung
biopsi
tissu
anoth
account
human
herpesviru
implic
polymeras
chain
reaction
test
tracheal
secret
lung
biopsi
specimen
sourc
fatal
viral
pneumon
immunocompet
patient
although
human
herpesviru
pneumonia
believ
highli
unusu
immunocompet
host
incid
may
underestim
clinician
routin
includ
viru
investig
panel
viral
pneumon
patient
contact
histori
skin
rash
clinic
compat
primari
infect
endogen
reactiv
furthermor
absenc
detect
human
herpesviru
dna
serum
reflect
transient
virem
phase
typic
primari
acut
infect
endogen
reactiv
hand
character
persist
viremia
latent
human
herpesviru
predominantli
incorpor
within
circul
lymphocyt
final
posit
nasopharyng
aspir
neg
serum
specimen
definit
exclud
chromosom
integr
human
herpesviru
inherit
condit
gener
associ
high
viral
load
circul
polymeras
chain
reaction
util
analyz
nasopharyng
aspir
patient
suspect
human
herpesviru
pneumonia
underscor
experi
asymptomat
shed
viru
saliva
welldocu
occurr
limit
valu
polymeras
chain
reaction
test
expector
sputum
specimen
even
bronchoscop
lavag
sampl
might
contain
oral
secret
although
shed
human
herpesviru
nasopharyng
aspir
rigor
studi
healthi
individu
simultan
perform
polymeras
chain
reaction
test
nasopharyng
aspir
specimen
adult
neg
human
herpesviru
dna
data
shown
suggest
asymptomat
shed
common
phenomenon
rare
occas
primari
human
herpesviru
infect
adult
caus
complic
possibl
fatal
outcom
moreov
emerg
pathogen
immunocompromis
patient
viral
reactiv
associ
interstiti
pneumon
enceph
acut
graftversushost
diseas
mortal
although
childhood
infect
ubiquit
mani
area
adult
seropreval
rate
vari
wide
among
differ
popul
rang
therefor
variabl
proport
adult
suscept
infect
later
life
patient
empir
treat
intraven
amoxicillinclavulan
oral
azithromycin
day
antibiot
discontinu
viral
caus
pneumonia
consid
like
fever
subsid
rash
cough
gradual
improv
discharg
day
well
followup
visit
drug
proven
clinic
effect
human
herpesviru
still
lack
rel
toxic
antivir
ganciclovir
foscarnet
cidofovir
use
treat
human
herpesviru
diseas
reactiv
howev
drug
toxic
reduc
drug
suscept
problem
pose
manag
difficulti
especi
immunocompromis
patient
antimalari
agent
artesun
report
vitro
efficaci
human
herpesviru
close
relat
cytomegaloviru
success
use
treat
patient
human
herpesviru
myocard
construct
differenti
diagnosi
physician
awar
human
herpesviru
potenti
culprit
atyp
pneumonia
adult
viru
may
overlook
popul
low
seropreval
